Rhythm, a company in the biomedical and genetics industry, outperformed the S&P 500 market index.
2 reports, 1 independent
Updated Aug 5
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Rhythm, a company in the biomedical and genetics industry, outperformed the S&P 500 market index.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Rhythm (United states)
company in Boston, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksRhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $0.75 per share versus the Zacks Consensus Estimate o